MétaCan
Menu
← Back to cohort

S5228 Real-World Use of EUS-Guided Ethanol Ablation for Small pNETs: Patient-Centered Alternatives to Surgery

2025· article· en· W4417196504 on OpenAlexaboutno aff
Adedamola Bello, Roberto Trasolini, Sidhartha Gupta

Bibliographic record

VenueThe American Journal of Gastroenterology · 2025
Typearticle
Languageen
FieldMedicine
TopicNeuroendocrine Tumor Research Advances
Canadian institutionsnot available
Fundersnot available
KeywordsMEN1InsulinomaAblationMultiple endocrine neoplasiaPancreatitisEndocrine systemAdverse effectHypoglycemiaPancreas

Abstract

fetched live from OpenAlex

Introduction: Pancreatic neuroendocrine tumors (pNETs) are increasingly diagnosed incidentally, with small, non-functional lesions often presenting a management dilemma. While surgical resection remains the standard of care for localized disease, it carries significant morbidity, particularly for lesions in the pancreatic head. Endoscopic ultrasound-guided ethanol ablation (EUS-EA) has emerged as a minimally invasive, pancreas-sparing alternative for select patients, including those who are medically inoperable, prefer organ-preserving therapy, or have hereditary tumor predisposition syndromes such as multiple endocrine neoplasia type 1 (MEN1). Despite growing international experience, real-world data on EUS-EA in Canadian practice remain limited. Case Description: We retrospectively reviewed 3 cases (ages 34-87) of biopsy-confirmed WHO Grade 1 pNETs measuring ≤1.5 cm, including one with MEN1 syndrome. All patients underwent EUS-guided ethanol ablation using 0.5-1.2 mL of 100% ethanol under conscious sedation. Procedures were performed by interventional endoscopists. Follow-up imaging at 3-6 months assessed treatment response, and patients were monitored clinically for complications and symptom recurrence. Discussion: All 3 patients underwent technically successful EUS-EA without procedure-related adverse events. Two achieved complete radiographic response after a single session. One elderly patient with recurrent insulinoma required a second ablation for residual disease, with resolution of hypoglycemia without recurrence. Functional outcomes were favorable across all cases. One patient had confirmed MEN1; genetic counseling and endocrine follow-up were arranged. No pancreatitis or bleeding occurred. This case series demonstrates the feasibility, efficacy, and safety of EUS-EA performed by interventional endoscopists for small, low-grade pNETs in a Canadian tertiary care setting. These findings support EUS-EA as a surgery-sparing option for carefully selected patients, particularly those unfit for resection or seeking minimally invasive alternatives. Our results align with emerging data on the use of ablative therapies in pNETs, demonstrating high technical success and favorable functional outcomes. Ongoing surveillance and larger prospective studies are warranted to define long-term durability and recurrence rates.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.006
Threshold uncertainty score0.021

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0060.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.359
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicNeuroendocrine Tumor Research Advances→French-language works237,207→